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Abstract 
Background and Objective: The survival-agreement plot was proposed and improved to assess 
the reliability of a quantitative measure. We propose the use of survival analysis as an alternative 
non-parametric approach for comparison of ordinal qualitative data. 
Study Design and Setting: Two case studies were presented. The first one is related to a 
randomized, double blind, placebo-controlled clinical trial to investigate the safety and efficacy of 
silymarin/metionin for chronic hepatitis C. The second one is a prospective study to identify 
gustatory alterations due to chorda tympani nerve involvement in patients with chronic otitis media 
without prior surgery. 
Results: No significant difference was detected between the two treatments related to the chronic 
hepatitis C (p > 0.5). On the other hand, a significant association was observed between the healthy 
side and the affected side of the face of patients with chronic otitis media related to gustatory 
alterations (p < 0.05). 
Conclusion: The proposed method can serve as an alternative procedure to statistical test for 
comparison of samples from ordinal qualitative variables. This approach has the advantage of being 
more familiar to clinical researchers. 
Keywords: Ordinal qualitative data; Agreement; Survival-agreement plot; Kaplan-Meier; 
Proportional hazards; Tarone-Ware test 
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What is New 
- A method for comparison of ordinal qualitative data using survival analysis is evaluated for the      
  first time. 
- A new application of a methodology more familiar to medical researchers. 
- An alternative non-parametric method to test equality of two or more samples. 
 
1. Introduction 
In clinical research, recent studies have been evaluating in order to assess agreement of 
quantitative data. Luiz et al. [1] proposed the survival-agreement plot approach to assess the 
reliability of a quantitative measure. The authors expressed the degree of agreement (or 
disagreement) of a measure as a function of several limits of tolerance, using the Kaplan-Meier [2] 
method, where the failures occur exactly at absolute values of the differences between the two 
methods, say A and B. According to the authors, the survival-agreement plot is a step function of a 
typical survival analysis without censored data, where the Y axis represents the proportion of 
discordant cases. This is equivalent to a step function where the X axis represents the absolute 
observed differences and the Y axis is the proportion of the cases with at least the observed 
difference (xi). 
An improvement on the Luiz et al. [1] method was suggested by Llorca and Delgado-Rodríguez 
[3], by considering two groups of the real differences (A < B and A > B) instead of the absolute 
values of the observed difference between the methods (|A – B|). Therefore, usual tests for 
comparisons of survival curves can be evaluated. 
In this paper we propose the use of survival analysis method for comparison of ordinal qualitative 
data. 
 
2. Data base and methods 
In this section two case studies are presented to illustrate the new approach by using survival 
analysis to assess agreement of the ordinal qualitative data. 
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The first one is related to chronic hepatitis C, which is a widespread infectious disease. The 
World Health Organization estimates that about 3% of the world’s population has been infected with 
hepatitis C virus and that some 170 million are chronic carriers [4]. Although specific antiviral 
therapy with interferon alpha plus ribavirin is strongly recommended to patients with progressive 
disease, the overall response rate is less than fifty percent [5]. Non responders have high risk of 
developing progressive hepatic fibrosis, and might be beneficiated by reversing it through the use of 
anti-fibrotic drugs. One of these drugs is silymarin, obtained from milk thistle and used since ancient 
times as a liver tonic, alone or combined with metionin [6]. To evaluate the safety and efficacy of 
silymarin/metionin for chronic hepatitis C a randomized, double blind, placebo-controlled clinical 
trial was conducted, in which both groups were concurrently treated with interferon alpha plus 
ribavirin. The primary efficacy end point was improvement of liver histology after treatment. 
Changes in histology were evaluated comparing previous and pos therapy biopsy features, according 
to the Ishak grading system [7] that classifies the degree of inflammation in nineteen grades (0 to 18) 
and the extent of fibrosis in seven stages (0 to 6).  
The second case study is related to 45 patients with chronic otitis media (COM), being 25 with 
cholesteatoma and 20 without cholesteatomatous COM, with a mean age of 38 years. Eight cases of 
unilateral ageusia were found on the affected side.  
A prospective study was performed to identify gustatory alterations due to chorda tympani nerve 
involvement in patients with chronic otitis media (COM) without prior surgery, and to find out 
whether the presence of cholesteatoma worsened gustatory sensitivity in these patients. The test was 
performed in patients with unilateral cholesteatomatous or suppurated COM not previously 
submitted to otological surgery. The test was based on “taste strips” with different concentrations of 
salt, sweet, bitter, and sour, using the otological disease free side as the control. The score could be 
between 0 (worst) and 16 (best). The data were collected by interview and physical exam. Patients 
with cholesteatomatous or suppurated COM may present gustatory alterations, even in the absence 
of complaints. 
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3. Results 
Figure 1 presents the survival curves related to 42 patients considered in the first case study, who 
were divided into two groups of treatments. These two groups were compared in the beginning and 
in the end of the study. The survivorship functions cross indicating that the proportional hazards 
assumption was violated. Therefore to test the equality of the two survivor functions the Tarone-
Ware test [8] was performed, which may be more powerful non-parametric weighted rank test than 
the alternatives log rank test and the modified Wilcoxon test. The results indicated no significant 
difference between the groups before and after treatment (p > 0.5). 
 
Figure 1 – Survival curves before and after treatment 
 
In the second case study, related to patients with chronic otitis media (COM), a Poisson 
regression and the above survival curve analysis was used. The covariates considered in this study 
were: age, gender, smoking, otorrhea, cholesteatoma, diabetes, and blood pressure. A typical result 
of the survival curve is shown in Figure 2 for comparison of the healthy and affected side. After 
performing the Tarone-Ware test [8], the results pointed out significant association between the 
healthy and affected side (p = 0.00239). 
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Figure 2 – Proportion of patients who recognized the flavors 
 
4. Conclusion 
We believe that the proposed survival curve approach can serve as an alternative procedure to 
statistical test for comparison of samples from ordinal qualitative variables. In addition, this new 
methodology may be more familiar to medical researchers. 
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